Activity of KIN-3248, a next-generation pan-FGFR inhibitor, against acquired FGFR-gatekeeper and molecular-brake drug resistance mutations-MedSci.cn

Activity of KIN-3248, a next-generation pan-FGFR inhibitor, against acquired FGFR-gatekeeper and molecular-brake drug resistance mutations

Franovic, A; Mohan, A; Uryu, S; Wu, QB; Jiang, P; Miller, N; Tyhonas, J; Timple, N; Severson, P; Kania, R; Murphy, E; Bardeesy, N; Martin, E

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (4):

科室
- - 订阅+
  - 更多科室
工具
服务